Info@ThinkPinkRocks.org

PROLOR Biotech, Inc. today reported top-line results from a Phase II four-month treatment extension study of hGH-CTP, its long-acting version of human growth hormone, in growth hormone deficient adults.

View article:
Positive results from PROLOR Biotech’s hGH-CTP Phase II trial for growth hormone deficiency

Scroll to Top